Option Care Health (NASDAQ:OPCH) Updates Q4 Earnings Guidance

Option Care Health (NASDAQ:OPCH) updated its fourth quarter earnings guidance on Monday. The company provided earnings per share guidance of $0.42-0.45 for the period, compared to the consensus earnings per share estimate of $0.35. The company issued revenue guidance of $1.34-1.35 billion, compared to the consensus revenue estimate of $1.27 billion. Option Care Health also updated its FY 2024 guidance to 1.550-1.590 EPS.

Option Care Health Trading Up 3.6 %

Shares of OPCH stock opened at $28.72 on Wednesday. The business has a 50-day moving average of $23.33 and a 200 day moving average of $27.70. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health has a 1-year low of $21.39 and a 1-year high of $34.63. The stock has a market capitalization of $4.89 billion, a PE ratio of 24.13, a P/E/G ratio of 2.43 and a beta of 1.31.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on OPCH. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their target price for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Barrington Research increased their target price on shares of Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a report on Tuesday. JMP Securities reissued a “market outperform” rating and issued a $30.00 target price (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Finally, UBS Group started coverage on Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective for the company. Three analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $29.86.

Insider Activity

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the stock in a transaction dated Friday, November 8th. The stock was purchased at an average price of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.